Innovating the Future of Tech: Revolka Co., Ltd. Pioneers New Solutions in AI and Robotics
RevolKa Ltd. a pioneering biotech firm at the forefront of AI-driven protein engineering, proudly announces the successful closure of its Series A extension funding, raising a total of 250 million JPY (approximately US$1.7 million). This latest infusion of capital, which includes a 100 million JPY (US$0.7 million) financing round, is poised to significantly enhance RevolKa’s…